Pharmaron Beijing Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 21,370 full-time employees. The company went IPO on 2019-01-28. Pharmaron Beijing Co Ltd is a China-based company providing research and manufacturing service portfolio, medical tools and clinical research testing services in the process of discovering, developing and manufacturing small molecule drugs, cell therapy and gene therapy. The firm operates in four segments. Laboratory Services segment includes laboratory chemistry, drug metabolism and pharmacokinetics/absorption, distribution, metabolism and excretion, biology, safety assessment and discovery of biological agents. CMC Service segment is engaged in process development and preform production and analysis. Clinical Development Service segment includes clinical research, on-site management organization, regulatory biological analysis and radioactive labeling scientific services. The Biologics and CGT Services segment is engaged in the discovery, development and production of macromolecular drugs, development of cell gene therapy methods and other businesses.
Follow-Up Questions
Who is the CEO of Pharmaron Beijing Co Ltd?
Mr. Boliang Lou is the Executive Chairman of the Board of Pharmaron Beijing Co Ltd, joining the firm since 2016.
What is the price performance of PHBBF stock?
The current price of PHBBF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Pharmaron Beijing Co Ltd?
Pharmaron Beijing Co Ltd belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Pharmaron Beijing Co Ltd market cap?
Pharmaron Beijing Co Ltd's current market cap is $0
Is Pharmaron Beijing Co Ltd a buy, sell, or hold?
According to wall street analysts, 13 analysts have made analyst ratings for Pharmaron Beijing Co Ltd, including 5 strong buy, 9 buy, 3 hold, 2 sell, and 5 strong sell
